Hoth Therapeutics Inc. (HOTH) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Hoth Therapeutics Inc.

    NASDAQ: HOTH · Real-Time Price · USD
    1.60
    -0.01 (-0.62%)
    At close: Sep 11, 2025, 3:59 PM
    1.60
    0.04%
    After-hours: Sep 11, 2025, 07:59 PM EDT

    Hoth Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a 66.83K 46.87M
    Gross Profit
    		 n/a n/a -66.83K -46.87M
    Operating Income
    		 -8.22M -7.69M -11.07M -14.1M
    Interest Income
    		 27.71K 51.77K 6.37K n/a
    Pretax Income
    		 -8.19M -7.85M -11.37M -14.31M
    Net Income
    		 -8.19M -7.85M -11.37M -14.31M
    Selling & General & Admin
    		 4.97M 4.21M 6.13M 6.57M
    Research & Development
    		 3.25M 3.48M 4.93M 7.53M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 8.22M 7.69M 11.07M 14.1M
    Interest Expense
    		 n/a n/a 305.41K n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 8.22M 7.69M 11.07M 14.1M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 6.38M 3.41M 1.2M 893.2K
    Shares Outstanding (Diluted)
    		 6.38M 3.41M 1.2M 893.2K
    EPS (Basic)
    		 -1.28 -2.3 -9.5 -16.03
    EPS (Diluted)
    		 -1.28 -2.3 -9.5 -16.03
    EBITDA
    		 -8.19M -153.15K n/a -14.1M
    EBIT
    		 -8.19M -7.85M -11.07M -14.1M
    Depreciation & Amortization
    		 8.22M 7.69M 11.07M 1.04K

    Add to Watchlist